Equinext formed a partnership with Hagyard Equine Medical Institute to bring a medical device to the equine market to treat tendon and ligament injuries and Wobbler's Syndrome in horses and other animals. Equinext will use its chemically-made injectable reagent device on these lower leg strains and sprains, which are very common in all types of performance horses and have a high rate of reoccurrence. Equinext is located at UK Coldstream Research Campus.
Contact: Eric Hauck, CEO
Address: 1501 Bull Lea Rd., Ste.103, Lexington, KY 40511